We are live on ! Find out more
ISLEW

Isleworth Healthcare Acquisition Corporation Warrant
ISLEW

Delisted

ISLEW was delisted on the 26th of August, 2022.

0 hedge funds and large institutions have $0 invested in Isleworth Healthcare Acquisition Corporation Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 460 (-46)

100% less capital invested

Capital invested by funds: $6.08M → $0 (-$6.08M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 46

Holders
Holders Change
-46
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
46
Calls
Puts
Net Calls
Net Calls Change

ISLEW Hedge Fund Activity: Q3 2022 in Review

0 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) for Q3 2022, worth a combined $0 — down 100% from $6.08M a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of ISLEW and 0 opened new positions — a net loss of 46 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $2.99M sold.

  • 0 institutional investors held Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) as of Q3 2022, down from 46 in Q2 2022.
  • Funds reported $0 of Isleworth Healthcare Acquisition Corporation Warrant stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Isleworth Healthcare Acquisition Corporation Warrant positions in Q3 2022 and 46 closed out, a net change of -46 holders.
  • The largest Isleworth Healthcare Acquisition Corporation Warrant seller in Q3 2022 was Radcliffe Capital Management, an estimated $2.99M sold.

Based on aggregated 13F filings for Q3 2022.